1-6 of 6
Michael Lübbert
Close
Sort by
Journal Articles

Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1 + /preBCR + ALL

Gaia Gentile, Teresa Poggio, Antonella Catalano, Minna Voutilainen, Mari Lahnalampi, Marta Andrade-Martinez, Tobias Ma, Roman Sankowski, Lina Goncharenko, Stefan Tholen, Kyuho Han, David W. Morgens, Marco Prinz, Michael Lübbert, Sophia Engel, Tanja Nicole Hartmann, Gunnar Cario, Martin Schrappe, Lennart Lenk, Martin Stanulla, Justus Duyster, Peter Bronsert, Michael C. Bassik, Michael L. Cleary, Oliver Schilling, Merja Heinäniemi, Jesús Duque-Afonso
Journal: Blood Advances
Blood Adv (2024) 8 (11): 2846–2860.
https://doi.org/10.1182/bloodadvances.2023011582
Published: 2024
Includes: Supplemental data
Journal Articles

Progenitor-like cell type of an MLL - EDC4 fusion in acute myeloid leukemia

Linda C. Schuster, Afzal P. Syed, Stephan M. Tirier, Simon Steiger, Isabelle Seufert, Heiko Becker, Jesus Duque-Afonso, Tobias Ma, Seishi Ogawa, Jan-Philipp Mallm, Michael Lübbert, Karsten Rippe
Journal: Blood Advances
Blood Adv (2023) 7 (22): 7079–7083.
https://doi.org/10.1182/bloodadvances.2022009096
Published: 2023
Includes: Supplemental data
Journal Articles

Midostaurin plus intensive chemotherapy for younger and older patients with AML and FLT3 internal tandem duplications

Clinical Trials & Observations
Hartmut Döhner, Daniela Weber, Julia Krzykalla, Walter Fiedler, Gerald Wulf, Helmut Salih, Michael Lübbert, Michael W. M. Kühn, Thomas Schroeder, Hans Salwender, Katharina Götze, Jörg Westermann, Lars Fransecky, Karin Mayer, Bernd Hertenstein, Mark Ringhoffer, Hans-Joachim Tischler, Sigrid Machherndl-Spandl, Anika Schrade, Peter Paschka, Verena I. Gaidzik, Frauke Theis, Felicitas Thol, Michael Heuser, Richard F. Schlenk, Lars Bullinger, Maral Saadati, Axel Benner, Richard Larson, Richard Stone, Konstanze Döhner, Arnold Ganser
Journal: Blood Advances
Blood Adv (2022) 6 (18): 5345–5355.
https://doi.org/10.1182/bloodadvances.2022007223
Published: 2022
Includes: Supplemental data
Journal Articles

Deferasirox-induced robust and dose-dependent reversal of anemia in a patient with variants in the TRIB2 and ABCB6 genes

Julia Stomper, Paulina Richter-Pechanska, Dietmar Pfeifer, Immacolata Andolfo, Achille Iolascon, Martina U. Muckenthaler, Michael Lübbert
Journal: Blood Advances
Blood Adv (2022) 6 (11): 3551–3555.
https://doi.org/10.1182/bloodadvances.2021006277
Published: 2022
Includes: Supplemental data
Journal Articles

Genomic heterogeneity in core-binding factor acute myeloid leukemia and its clinical implication

Clinical Trials & Observations
Nikolaus Jahn, Tobias Terzer, Eric Sträng, Anna Dolnik, Sibylle Cocciardi, Ekaterina Panina, Andrea Corbacioglu, Julia Herzig, Daniela Weber, Anika Schrade, Katharina Götze, Thomas Schröder, Michael Lübbert, Dominique Wellnitz, Elisabeth Koller, Richard F. Schlenk, Verena I. Gaidzik, Peter Paschka, Frank G. Rücker, Michael Heuser, Felicitas Thol, Arnold Ganser, Axel Benner, Hartmut Döhner, Lars Bullinger, Konstanze Döhner
Journal: Blood Advances
Blood Adv (2020) 4 (24): 6342–6352.
https://doi.org/10.1182/bloodadvances.2020002673
Published: 2020
Includes: Supplemental data
Journal Articles

Identification of enhancer of mRNA decapping 4 as a novel fusion partner of MLL in acute myeloid leukemia

Heiko Becker, Gabriele Greve, Keisuke Kataoka, Jan-Philipp Mallm, Jesús Duque-Afonso, Tobias Ma, Christoph Niemöller, Milena Pantic, Justus Duyster, Michael L. Cleary, Julia Schüler, Karsten Rippe, Seishi Ogawa, Michael Lübbert
Journal: Blood Advances
Blood Adv (2019) 3 (5): 761–765.
https://doi.org/10.1182/bloodadvances.2018023879
Published: 2019
Includes: Supplemental data